\"Excellent drug needs and advanced preparation technology organically combined, the location of the product needs to pay attention to market differentiation, the R & D project must meet the needs of the blank field, is the three challenges faced by the development of the high-end formulation industry.\" Former Vice President of Mei Lan Company, Dr. Srinivasan, for the high-end preparation technology and industry development forum, made a wonderful speech for the current high-end preparation and future trend of the world, and the Forum was held at the Nanjing International Expo Convention Center on December 10, 2019. The guests sharing academic achievements also have a professor of the former president of the School of Pharmaceutical University, Professor Qiang Feng, Associate President of Tsinghua University School of Pharmaceutical College, Dr. Guo Xiaidi, Zhejiang Huahai Pharmaceutical, Dr. Guo Xiandi, Hong Kong University of Science and Technology Dr. Jiangzi, Jiangsu Jijin Pharmaceutical Preparation Technology, Dr. Danyi, many domestic and foreign high-end formulations, top experts and entrepreneurs in the field of high-end formulations and entrepreneurship, will have a variety of advanced academics
I. Project Name: GMP Passenger Platform Project II, Construction Location: Jiangsu Province, Jiangbei New District Biomedical Valley Preparation Accelerator Plant 1 III, Construction Unit: Jiangsu Crafts New Drug Preparation Technology Research Institute Co., Ltd. IV, Construction Project Overview: Jiangsu Jijin New Drug Preparation Technology Research Institute Co., Ltd. rental, Jiangbei New District Biomedical Valley Preparation Accelerator Plant 1 factory building (total construction area 11114.5 square meters) Construction of a variety of dosage forms (65% of total construction area), office , Lab, warehouse (35% of total construction area) and installation of formulation production lines and construction of related supporting equipment. The specific design annual production capacity is: tablets (19 million pieces), capsules (soft 24 million, hard 4 million), injection (400,000 bottles), suspension (400,000 bottles), transdermal preparation (stickers 3 million paste, 1 million external formulations), implant (
